<DOC>
	<DOCNO>NCT00759291</DOCNO>
	<brief_summary>This study test hypothesis reduce release free fatty acid ( FFA ) fat cell restore insulin-mediated , endothelium-dependent vasodilation people metabolic syndrome .</brief_summary>
	<brief_title>The Impact Free Fatty Acid Reduction Vascular Function Metabolic Syndrome</brief_title>
	<detailed_description>We hypothesize acipimox , decrease plasma FFA concentration , augment endothelium-dependent vasodilation conduit vessel insulin-mediated vasodilation forearm resistance arteriole vivo , whole-body insulin sensitivity , AKT ( also know Protein Kinase B ) endothelial nitric oxide synthase ( eNOS ) phosphorylation skin biopsy specimen ex vivo , compare placebo .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Acipimox</mesh_term>
	<criteria>Adults metabolic syndrome , define presence 3 5 component syndrome define National Cholesterol Education Program include : abdominal obesity elevate fast blood sugar ( 110 mg/dL &lt; glucose &lt; 126 mg/dL ) low HDL elevate fast blood triglyceride ( &gt; 150 mg/dL ) hypertension ( BP &gt; 140/90 mm HG ) Normal cardiovascular examination Diabetes mellitus Untreated hypercholesterolemia ( LDL &gt; 75th percentile age ) Cigarette smoke within 1 year Renal insufficiency ( creatinine &gt; 1.4 mg/dl ) Blood dyscrasia Hepatic dysfunction ( ALT &gt; 2x normal ) Evident coronary/peripheral atherosclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>free fatty acid</keyword>
	<keyword>insulin-mediated</keyword>
	<keyword>endothelium-dependent vasodilation</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>